• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达鲁的药品质量控制工作:1983 - 1986年期间的观察

Drug quality control work in Daru: observations during 1983-1986.

作者信息

Kibwage I O, Ogeto J O, Maitai C K, Rutere G, Thuranira J, Ochieng' A

机构信息

Department of Pharmacy, University of Nairobi.

出版信息

East Afr Med J. 1992 Oct;69(10):577-80.

PMID:1473513
Abstract

During a 4 year period (January 1983 to December 1986), 418 requests for drug analysis were received in the Drug Analysis and Research Unit, Department of Pharmacy, University of Nairobi. Of these requests, 212 were from Medical Supplies Coordination Unit, 190 from Government hospitals and health research institutions, 11 from the Ministry of Health Headquarters (Director of Medical Services and Chief Pharmacist) and 5 came from local pharmaceutical manufacturers. Of the samples analysed, 70.8% were from local manufacturers, 26.1% were imported and 3.1% were from undeclared sources. Failure to comply with test for quality, as set out in official compendia (B.P. Eur. ph. Ip, etc.) were observed at 45.8% for locally manufactured drugs and 31.4% for imported drug products.

摘要

在1983年1月至1986年12月的4年期间,内罗毕大学药学院药物分析与研究部门收到了418份药物分析请求。其中,212份来自医疗用品协调部门,190份来自政府医院和健康研究机构,11份来自卫生部总部(医疗服务主任和首席药剂师),5份来自当地制药商。在分析的样本中,70.8%来自当地制造商,26.1%是进口的,3.1%来源不明。发现当地生产的药品有45.8%、进口药品有31.4%不符合官方药典(欧洲药典、英国药典、印度药典等)规定的质量检测标准。

相似文献

1
Drug quality control work in Daru: observations during 1983-1986.达鲁的药品质量控制工作:1983 - 1986年期间的观察
East Afr Med J. 1992 Oct;69(10):577-80.
2
[An analysis of the pharmaceuticals market in Vietnam].[越南药品市场分析]
Sante. 2001 Jul-Sep;11(3):155-60.
3
3. Drug regulations in Switzerland and their application.3. 瑞士的药品法规及其应用。
Bull Parenter Drug Assoc. 1974 Jul-Aug;28(4):167-73.
4
[Guidelines for introducing new drugs for medical use in Poland and control of their quality].[波兰医用新药引进及质量控制指南]
Pol Tyg Lek. 1984;39(51-52):1673-4.
5
Pharmacopoeia as quality codex for the manufacturers.药典作为制造商的质量法典。
Ann Ist Super Sanita. 1975;11(3-4):269-80.
6
QUAD routes out inferior drugs.四方查处劣质药品。
Can Hosp. 1973 May;50(5):58-9.
7
Rationale drug therapy: reasons for failure and suggestions for its implementation.合理药物治疗:失败原因及其实施建议。
Indian Pediatr. 1993 Jun;30(6):815-8.
8
WHO Expert Committee on specifications for pharmaceutical preparations.世界卫生组织药物制剂规范专家委员会
World Health Organ Tech Rep Ser. 2010(957):1-276, back cover.
9
Development of specifications for biotechnology products--perspective from Europe.生物技术产品规范的制定——欧洲视角
Dev Biol Stand. 1997;91:25-30.
10
WHO Expert Committee on Specifications for Pharmaceutical Preparations.世界卫生组织药物制剂规范专家委员会
World Health Organ Tech Rep Ser. 2005;929:1-142, backcover.

引用本文的文献

1
In-vitro evaluation of the quality of paracetamol and co-trimoxazole tablets used in Malawi based on pharmacopoeial standards.基于药典标准对马拉维使用的对乙酰氨基酚和复方新诺明片剂质量的体外评估。
Malawi Med J. 2014 Jun;26(2):38-41.
2
Antimalarial drug quality in Africa.非洲抗疟药物的质量
J Clin Pharm Ther. 2007 Oct;32(5):429-40. doi: 10.1111/j.1365-2710.2007.00847.x.